Nuclear Medicine/Radiopharmaceuticals Market is Projected to Reach US$ 5.0 Billion Globally By 2022

The global nuclear medicine/radiopharmaceuticals market is also segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is estimated to be the largest nuclear medicine/radiopharmaceuticals market. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, and Brazil. The report includes a detailed study of global and regional nuclear medicine/radiopharmaceuticals market and analyzes the variations in the growth of the industry in certain regions.

The global nuclear medicine/radiopharmaceuticals market is expected to reach US$ 4.0 billion by 2020, registering a CAGR of 9.0% during the forecast period.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market

Cardinal Health, Inc. (U.S.), GE Healthcare (U.K.), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), Bayer Healthcare (Germany), Lantheus Medical Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), and Mallinckrodt Plc (Ireland) are the most active players in the nuclear medicine/radiopharmaceuticals market.

Advancement in radiotracers and alpha radio immunotherapy-based targeted cancer treatment is primarily driving the nuclear medicine/radiopharmaceuticals market. In addition, the increasing use of SPECT and PET scans to detect diseases like cancer and the growing occurrence of cancer and cardiac ailments are driving the market. However, conventional diagnostic procedures are still followed in most hospitals due to cost and availability issues associated with nuclear medicine/radiopharmaceuticals, which is expected to hamper the growth of the market. In addition, the short lifespan of nuclear medicine/radiopharmaceuticals and stringent regulatory guidelines are expected to restrain the growth of the market.

We provide customization of the report to early buyers, as per requirement.

In this report, the global nuclear medicine/radiopharmaceuticals market is segmented by type, application, procedural volume, and region. Each of these segments contains diagnostic and therapeutic types. Based on type, the market is segmented into diagnostic and therapeutic nuclear medicine/radiopharmaceuticals. The diagnostic segment accounts for the largest share of the global market by type. In the diagnostic segment, the SPECT segment accounts for the largest share of the market whereas, in the therapeutic segment, the beta emitters segment holds the largest market share.

Request Free Sample Report: https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market

Based on application, the market is segmented into diagnostic and therapeutic applications. The diagnostic application contains SPECT (cardiology, thyroid, neurology, and others) and PET (oncology, cardiology, and neurology). Nuclear medicine is used in different therapeutic applications such as bone metastasis, thyroid, lymphoma, and endocrine tumors.

Table of Contents

1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Investments Through Public-Private Partnerships to Modernize Diagnostic Imaging Centers
5.2.1.2 Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
5.2.1.3 Advances in Radiotracers
5.2.1.4 Increasing Incidence and Prevalence of Cancer and Cardiac Ailments
5.2.2 Restraints
5.2.2.1 Shorter Half-Life of Radiopharmaceuticals
5.2.2.2 High Cost of Nuclear Medicine Equipment
5.2.3 Opportunities
5.2.3.1 High Demand in Emerging Markets
5.2.3.2 Upcoming Radioisotopes
5.2.3.3 Use of Radiopharmaceuticals in Neurological Applications
5.2.4 Challenges
5.2.4.1 Shutdown of Nuclear Reactors
6 Nuclear Medicine Market, By Type
7 Nuclear Medicine Market, By Application
8 Nuclear Medicine Market, By Procedural Volume
9 Global Nuclear Medicine Market, By Region
10 Global Nuclear Medicine Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1 Introduction
12.2 Cardinal Health, Inc.
12.3 Mallinckrodt PLC
12.4 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
12.5 Lantheus Medical Imaging, Inc.
12.6 Bayer AG
12.7 Bracco Imaging S.P.A
12.8 Eczacibasi-Monrol Nuclear Products
12.9 Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)
12.10 Advanced Accelerator Applications S.A.
12.11 IBA Molecular

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.